VBI.H — Vivione Biosciences Income Statement

0.000.00%

Last trade - 00:00

FinancialsMicro Cap

Annual income statement for Vivione Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2013 December 31st	2014 December 31st	2015 December 31st	2016 December 31st	2017 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0.356	0.066	0.224	0	0
Cost of Revenue
Gross Profit	0.097	-0.012	0.029	0	—
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	2.93	3.47	2.05	0.085	0.129
Operating Profit	-2.58	-3.4	-1.83	-0.085	-0.129
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-3.8	-3.41	1.39	-0.085	-0.132
Provision for Income Taxes
Net Income After Taxes	-3.82	-3.4	1.4	-0.085	-0.132
Net Income Before Extraordinary Items
Net Income	-3.82	-3.4	1.4	-0.085	-0.132
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-3.82	-3.4	1.4	-0.085	-0.132
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.068	-0.051	0.02	-0.002	-0.002
Dividends per Share